BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19777621)

  • 1. Repetitive response to gemcitabine that led to curative resection in cholangiocarcinoma.
    Kim SH; Kim IH; Kim SW; Lee SO
    World J Gastroenterol; 2009 Sep; 15(36):4593-5. PubMed ID: 19777621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-surviving patient with hilar cholangiocarcinoma by gemcitabine monotherapy].
    Iwata N; Yoshida T; Katsuta E; Aoyagi H; Takahata T; Hasegawa K; Kaneko J; Maejima S
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2116-8. PubMed ID: 23267995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single-center study.
    Kato A; Shimizu H; Ohtsuka M; Yoshidome H; Yoshitomi H; Furukawa K; Takeuchi D; Takayashiki T; Kimura F; Miyazaki M
    Ann Surg Oncol; 2013 Jan; 20(1):318-24. PubMed ID: 23149849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of advanced cholangiolocellular carcinoma successfully treated by neoadjuvant chemotherapy with gemcitabine followed by radical resection].
    Kawashima H; Takeda Y; Nakahira S; Mukai Y; Hamanaka M; Uchiyama C; Kanemura T; Okishiro M; Takeno A; Suzuki R; Taniguchi H; Nakata K; Egawa C; Miki H; Kato T; Tamura S
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2113-5. PubMed ID: 23267994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The possibility of local control of cancer by neoadjuvant chemoradiation therapy with gemcitabine and surgical resection for advanced cholangiocarcinoma].
    Nakagawa K; Katayose Y; Rikiyama T; Okaue A; Unno M
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2009-11. PubMed ID: 20037307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of intrahepatic cholangiocarcinoma with peritoneal dissemination treated successfully with surgical resection and adjuvant chemotherapy].
    Shiozaki S; Satoh D; Matsukawa H; Yamaguchi K; Takahashi K; Mimura N; Taguchi K; Araki H; Toshima T; Kato T; Miyake S; Miyoshi H; Yoshida K; Choda Y; Tokumoto N; Kanazawa T; Harano M; Ojima Y; Idani H; Okajima M; Ninomiya M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2089-91. PubMed ID: 25731432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant gemcitabine therapy improves survival in a locally induced, R0-resectable model of metastatic intrahepatic cholangiocarcinoma.
    Gürlevik E; Fleischmann-Mundt B; Armbrecht N; Longerich T; Woller N; Kloos A; Hoffmann D; Schambach A; Wirth TC; Manns MP; Zender L; Kubicka S; Kühnel F
    Hepatology; 2013 Sep; 58(3):1031-41. PubMed ID: 23686746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of curatively resected advanced intrahepatic cholangiocellular carcinoma through effective response to neoadjuvant chemotherapy].
    Hashimoto K; Tono T; Nishida K; Nonaka R; Tsunashima R; Fujie Y; Fujita S; Fujita J; Yoshida T; Ohnishi T; Imaoka S; Monden T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2083-5. PubMed ID: 25731430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A long-term survival case of unresectable intrahepatic cholangiocarcinoma treated with chemotherapy].
    Tamura T; Mizuyama Y; Shinto O; Nishihara T; Nakagawa H; Ono Y
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2732-4. PubMed ID: 21224695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic intraarterial chemotherapy with gemcitabine in patients with unresectable cholangiocarcinomas and liver metastases of pancreatic cancer: a clinical study on maximum tolerable dose and treatment efficacy.
    Vogl TJ; Schwarz W; Eichler K; Hochmuth K; Hammerstingl R; Jacob U; Scheller A; Zangos S; Heller M
    J Cancer Res Clin Oncol; 2006 Nov; 132(11):745-55. PubMed ID: 16858591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma.
    Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Kondo N; Sakabe R; Ohge H; Sueda T
    Ann Surg Oncol; 2011 Mar; 18(3):651-8. PubMed ID: 20945107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant surgery for advanced extrahepatic cholangiocarcinoma.
    Oshiro Y; Takahashi K; Sasaki R; Kondo T; Sakashita S; Ohkohchi N
    World J Gastroenterol; 2013 Oct; 19(40):6934-8. PubMed ID: 24187473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I/II study of hepatic arterial infusion chemotherapy with gemcitabine in patients with unresectable intrahepatic cholangiocarcinoma (JIVROSG-0301).
    Inaba Y; Arai Y; Yamaura H; Sato Y; Najima M; Aramaki T; Sone M; Kumada T; Tanigawa N; Anai H; Yoshioka T; Ikeda M;
    Am J Clin Oncol; 2011 Feb; 34(1):58-62. PubMed ID: 20177362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of intrahepatic recurrence of intrahepatic cholangiocarcinoma treated with repeated hepatectomy].
    Shimizu J; Dono K; Nagai K; Miyake M; Hata T; Kawanishi K; Fujita J; Ikeda K; Akagi K; Iwazawa T; Kitada M; Shimano T
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2469-71. PubMed ID: 22202416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma.
    Maithel SK; Keilson JM; Cao HST; Rupji M; Mahipal A; Lin BS; Javle MM; Cleary SP; Akce M; Switchenko JM; Rocha FG
    Ann Surg Oncol; 2023 Oct; 30(11):6558-6566. PubMed ID: 37368098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome.
    Dumitrascu T; Chirita D; Ionescu M; Popescu I
    J Gastrointest Surg; 2013 May; 17(5):913-24. PubMed ID: 23319395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human equilibrative nucleoside transporter 1 expression predicts survival of advanced cholangiocarcinoma patients treated with gemcitabine-based adjuvant chemotherapy after surgical resection.
    Kobayashi H; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Kondo N; Sueda T
    Ann Surg; 2012 Aug; 256(2):288-96. PubMed ID: 22580938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane Localization of Human Equilibrative Nucleoside Transporter 1 in Tumor Cells May Predict Response to Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients.
    Brandi G; Deserti M; Vasuri F; Farioli A; Degiovanni A; Palloni A; Frega G; Barbera MA; de Lorenzo S; Garajova I; Di Marco M; Pinna AD; Cescon M; Cucchetti A; Ercolani G; D'Errico-Grigioni A; Pantaleo MA; Biasco G; Tavolari S;
    Oncologist; 2016 May; 21(5):600-7. PubMed ID: 27032872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of curative resection after downsizing chemotherapy in initially unresectable locally advanced intrahepatic cholangiocarcinoma].
    Aoki Y; Suzuki T; Kato A; Shimizu H; Ohtsuka M; Yoshitomi H; Furukawa K; Takayashiki T; Kuboki S; Takano S; Okamura D; Suzuki D; Sakai N; Kagawa S; Miyazaki M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1509-11. PubMed ID: 25731235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine and Cisplatin as Neo-Adjuvant for Cholangiocarcinoma Patients Prior to Liver Transplantation: Case-Series.
    Abdelrahim M; Al-Rawi H; Esmail A; Xu J; Umoru G; Ibnshamsah F; Abudayyeh A; Victor D; Saharia A; McMillan R; Al Najjar E; Bugazia D; Al-Rawi M; Ghobrial RM
    Curr Oncol; 2022 May; 29(5):3585-3594. PubMed ID: 35621680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.